Article
Harnessing the potential of monocytes/macrophages to regenerate tissue-engineered vascular grafts.
Cardiovascular research - 2 Jul 2024
Das Arundhati, Smith Randall J, Andreadis Stelios T
Abstract excerpt
Cell-free tissue-engineered vascular grafts provide a promising alternative to treat cardiovascular disease, but timely endothelialization is essential for ensuring patency and proper functioning post-implantation. Recent studies from our lab showed that blood cells like monocytes (MCs) and macrophages (Mϕ) may contribute directly to cellularization and regeneration of bioengineered arteries in small and large...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
